Edition:
India

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.30USD
2:29am IST
Change (% chg)

$0.09 (+44.93%)
Prev Close
$0.21
Open
$0.23
Day's High
$0.31
Day's Low
$0.23
Volume
12,028,476
Avg. Vol
521,188
52-wk High
$2.85
52-wk Low
$0.12

Latest Key Developments (Source: Significant Developments)

Bigger Capital Fund Reports An 8 Pct Passive Stake In Akers Biosciences
Wednesday, 3 Jan 2018 

Jan 2 (Reuters) - Biosciences Inc ::BIGGER CAPITAL FUND LP REPORTS AN 8 PCT PASSIVE STAKE IN AKERS AS OF DEC 21, 2017 - SEC FILING.  Full Article

Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences
Saturday, 23 Dec 2017 

Dec 22 (Reuters) - Alpha Capital Anstalt::ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING.  Full Article

Akers Biosciences says Q3 revenue rose 10 pct to $675,800
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Akers Biosciences Inc -:Akers Biosciences announces Q3 2017 earnings.Q3 revenue rose 10 percent to $675,800.Akers Biosciences Inc - ‍Q3 gross margin reduced to 52%​.  Full Article

Akers Biosciences settles, to sell breath technology tests
Saturday, 20 Aug 2016 

Akers Biosciences Inc : Settles dispute with Chube, Thirty Six Strategies Llc , Gavin Moran, Frank Runge - SEC Filing .Co can sell all of breath technology tests worldwide, unencumbered by past or future claims by Chube under licensing agreement.  Full Article

Akers Biosciences Q2 loss before income tax $1 million
Thursday, 11 Aug 2016 

Akers Biosciences Inc : Akers Biosciences announces h1 and q2 2016 earnings .Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015..  Full Article

Akers Biosciences signs deal for Breathscan Oxichek(tm)
Monday, 27 Jun 2016 

Akers Biosciences Inc :Akers Biosciences signs distribution agreement for Breathscan Oxichek(tm).  Full Article

BRIEF-Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences

* ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING Source text (http://bit.ly/2BZ9Q04) Further company coverage: